Prolonged antigen‐exposure with carbohydrate particle based vaccination prevents allergic immune responses in sensitized mice

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  2009-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1398-9995.2008.01905.xPMID 19183417
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Carbohydrate‐based particles reduce allergic inflammation in a mouse model for cat allergy

  2008cited by this paper
• Chitosan solution enhances both humoral and cell-mediated immune responses to subcutaneous vaccination.

  2007cited by this paper
• Prolonged inhaled allergen exposure can induce persistent tolerance.

  2007cited by this paper
• Epigenetic Control of the foxp3 Locus in Regulatory T Cells

  2007cited by this paper
• Immunological mechanisms of allergen-specific immunotherapy

  2006cited by this paper
• Pathogen recognition and development of particulate vaccines: does size matter?

  2006cited by this paper
• Saponin-adjuvanted particulate vaccines for clinical use.

  2006cited by this paper
• Selenolthiol and Dithiol C‐Terminal Tetrapeptide Motifs for One‐Step Purification and Labeling of Recombinant Proteins Produced in E. coli

  2006cited by this paper
• Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.

  2006cited by this paper
• Cell-mediated immunity and the challenges for vaccine development.

  2006cited by this paper
• A mouse model for in vivo tracking of the major dust mite allergen Der p 2 after inhalation

  2005cited by this paper
• Nineteen cases of persistent pruritic nodules and contact allergy to aluminium after injection of commonly used aluminium-adsorbed vaccines

  2005cited by this paper
• Immunity in response to particulate antigen-delivery systems.

  2005cited by this paper
• A novel adjuvant–allergen complex, CBP–rFel d 1, induces up‐regulation of CD86 expression and enhances cytokine release by human dendritic cells in vitro

  2004cited by this paper
• Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence.

  2004cited by this paper
• Generation of Anergic and Regulatory T Cells following Prolonged Exposure to a Harmless Antigen 1

  2004cited by this paper
• Formation of Disulfide Bonds and Homodimers of the Major Cat Allergen Fel d 1 Equivalent to the Natural Allergen by Expression in Escherichia coli*

  2003cited by this paper
• Carbohydrate‐based particles: a new adjuvant for allergen‐specific immunotherapy

  2002cited by this paper
• T-bet regulates IgG class switching and pathogenic autoantibody production

  2002cited by this paper
• Antigen presentation and T cell stimulation by dendritic cells.

  2002cited by this paper
• Microparticle vaccine approaches to stimulate mucosal immunisation.

  2001cited by this paper
• The role of the adsorption process for production and control combined adsorbed vaccines.

  2001cited by this paper
• Oral Administration of Chitin Down-Regulates Serum IgE Levels and Lung Eosinophilia in the Allergic Mouse1

  2000cited by this paper
• Analysis of MHC class II presentation of particulate antigens of B lymphocytes.

  1996cited by this paper
• Adjuvants for human vaccines--current status, problems and future prospects.

  1995cited by this paper
• Role of F4/80+ cells during induction of hapten-specific contact hypersensitivity.

  1995cited by this paper
• Whole-body autoradiography.

  1981cited by this paper
• Whole-Body Autoradiography

  1981cited by this paper

• Application of Nanoparticles for Immunotherapy of Allergic Rhinitis

  2024cites this paper
• Nanoparticles in allergen immunotherapy

  2021cites this paper
• Current possibilities and future perspectives for improving efficacy of allergen-specific sublingual immunotherapy.

  2021cites this paper
• Allergen Immunotherapy in Pediatric Respiratory Allergy

  2021cites this paper
• Mucosal Vaccines for Allergy and Tolerance

  2020cites this paper
• Highlights of Novel Vaccination Strategies in Allergen Immunotherapy.

  2020cites this paper
• Design, production and immunomodulatory potency of a novel allergen bioparticle

  2020cites this paper
• Formulations for Allergen Immunotherapy in Human and Veterinary Patients: New Candidates on the Horizon

  2020cites this paper
• Immunotherapy in allergic diseases - improved understanding and innovation for enhanced effectiveness.

  2020cites this paper
• Recent advances in the use of nanoparticles for allergen‐specific immunotherapy

  2017cites this paper
• Allergen‐specific immunotherapy: is it vaccination against toxins after all?

  2017cites this paper
• Nanoparticle impact on innate immune cell pattern-recognition receptors and inflammasomes activation.

  2017cites this paper
• Nanoparticle–allergen complexes for allergen immunotherapy

  2017cites this paper
• Prophylactic immunization of mice with phospholipase A2‐loaded gas‐filled microbubbles is protective against Th2‐mediated honeybee venom allergy

  2016cites this paper
• Uniform-sized particles in biomedical field prepared by membrane emulsification technique

  2015cites this paper
• Advances in allergen immunotherapy: Aiming for complete tolerance to allergens

  2015cites this paper
• Nanoparticles Adjuvants in Allergology: New Challenges and Pitfalls.

  2015cites this paper
• New Vaccines for Mammalian Allergy Using Molecular Approaches

  2014cites this paper
• Glycoproteomic Analysis of Seven Major Allergenic Proteins Reveals Novel Post-translational Modifications*

  2014cites this paper
• Novel immunotherapy vaccine development

  2014cites this paper
• New treatments for allergen immunotherapy

  2014cites this paper
• Development of a Mouse Model for Chronic Cat Allergen-Induced Asthma

  2014cites this paper
• Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals.

  2014cites this paper
• Allergie aux phanères de chat. Place de l’immunothérapie

  2013cites this paper
• New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates

  2013cites this paper
• Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.

  2013cites this paper
• mRNA vaccination as a safe approach for specific protection from type I allergy

  2012cites this paper
• An alternative allergen:adjuvant formulation potentiates the immunogenicity and reduces allergenicity of a novel subcutaneous immunotherapy product for treatment of grass‐pollen allergy

  2012cites this paper
• ALLERGY TO PETS; MOLECULAR APPROACHES FOR IMPROVED DIAGNOSTICS AND VACCINATION

  2012cites this paper
• Defective aeroallergen surveillance by airway mucosal dendritic cells as a determinant of risk for persistent airways hyper-responsiveness in experimental asthma

  2012cites this paper
• Immune regulation and modulation of allergy and inflammatory diseases

  2012cites this paper
• Therapies for allergic inflammation: refining strategies to induce tolerance

  2012cites this paper
• Treatment with a Fel d 1 hypoallergen reduces allergic responses in a mouse model for cat allergy

  2011cites this paper
• Improved immune responses in mice using the novel chitosan adjuvant ViscoGel, with a Haemophilus influenzae type b glycoconjugate vaccine.

  2011cites this paper
• Mechanisms of IgE-mediated allergy.

  2010cites this paper
• Development of a Sel-tag for Multimodality Imaging and Studies of Mammalian Thioredoxin Reductase 1

  2010cites this paper
• INNATE MECHANISMS REGULATING PERIPHERAL B CELL TOLERANCE

  2010cites this paper
• Recombinant Bet v 1 vaccine for treatment of allergy to birch pollen

  2010cites this paper
• The impact of molecular biology on allergen immunotherapy

  2010cites this paper
• The Major Cat Allergen, Fel d 1, in Diagnosis and Therapy

  2009cites this paper
• RECOMBINANT CAT AND MITE ALLERGENS AS TOOLS IN THE STUDY OF DIAGNOSIS AND TREATMENT OF ALLERGY

  2009cites this paper